0001213900-21-021025.txt : 20210409 0001213900-21-021025.hdr.sgml : 20210409 20210409161537 ACCESSION NUMBER: 0001213900-21-021025 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210407 FILED AS OF DATE: 20210409 DATE AS OF CHANGE: 20210409 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Rothbard Jonathan B. CENTRAL INDEX KEY: 0001833968 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38105 FILM NUMBER: 21818018 MAIL ADDRESS: STREET 1: 501 BEALE STREET STREET 2: UNIT 8D CITY: SAN FRANCISCO STATE: CA ZIP: 94105 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: 180 Life Sciences Corp. CENTRAL INDEX KEY: 0001690080 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 813832378 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 830 MENLO AVENUE, SUITE 100 CITY: MENLO PARK STATE: CA ZIP: 94025 BUSINESS PHONE: 650-507-0669 MAIL ADDRESS: STREET 1: 830 MENLO AVENUE, SUITE 100 CITY: MENLO PARK STATE: CA ZIP: 94025 FORMER COMPANY: FORMER CONFORMED NAME: KBL MERGER CORP. IV DATE OF NAME CHANGE: 20161115 4 1 ownership.xml OWNERSHIP DOCUMENT X0306 4 2021-04-07 0 0001690080 180 Life Sciences Corp. ATNF 0001833968 Rothbard Jonathan B. 830 MENLO AVENUE, SUITE 100 MENLO PARK CA 94025 0 1 0 0 Chief Scientific Officer Common Stock 2021-04-07 4 A 0 24307 6.14 A 560449 D Issued in consideration for accrued compensation due for services rendered as Chief Scientific Officer of the Issuer. Granted under the registrant's 2020 Omnibus Incentive Plan. Exempt from Section 16(b) pursuant to Rule 16b-3. /s/ Jonathan B. Rothbard, Ph.D. 2021-04-09